Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease.Statement On A Nonproprietary Name Adopted By The…
Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease.Statement On A Nonproprietary Name Adopted By The USAN Council - Inclacumab, American Medical Association.
The antibody is outlicensed by Roche.
References
Gebaseerd op: Wikipedia — Inclacumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.